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 Abstract
Objective: Gap junctions (formed by connexins, Cx) are important for functional coordination of cells in the vascular wall. However,
little is known about their physiological regulation in this tissue. We examined the effects of nitric oxide (NO), an important mediator of
vasomotion, wound healing and angiogenesis, on the formation of gap junctions in endothelial cells (human umbilical vein endothelial cells,
HUVEC). Methods: Flow cytometry was used to determine dye transfer through newly formed gap junctions between acutely coincubated
HUVECs. Parallel experiments in wild-type HeLa cells (no connexins) and transfected HeLa cells exclusively expressing Cx43, Cx40 or
Cx37 were performed to determine the specific role of Cx subtypes. The intracellular distribution of Cx40 was examined after fractionation
with triton by Western blotting. Intracellular levels of cGMP and cAMP were measured by radioimmunoassay. Results: The NO donor
SNAP (1 AM) enhanced gap-junctional coupling in HUVECs by about 40%. This was associated with an enhanced incorporation of Cx40
into the membrane. Both effects were restricted to Cx40 as analyzed in experiments with Cx-selective HeLa cells. The NO-induced increase
in cell coupling was elicited by a corresponding rise of cGMP, which secondarily increased intracellular cAMP levels. The latter was an
integral part of the signal cascade, since the protein kinase A (PKA) inhibitor H89 blocked the SNAP-induced incorporation of Cx40 into the
plasma membrane. Conclusions: We conclude that NO is a potent modulator of gap-junctional coupling in endothelial cells. It enhances de
novo formation of endothelial gap junctions by increasing incorporation of Cx40 into the plasma membrane due to PKA activation.
D 2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved. sbibliothek M
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Transmission of signals from one cell to another through
the exchange of ions, metabolites or second messengers (e.g.
cAMP or cGMP) maintains cellular and tissue homeostasis.
Therefore, in most tissues, the cytoplasms of individual cells
are metabolically and/or electrically coupled to that of neigh-
boring cells through gap junctions [1]. The basic subunits of
gap junctions are connexins (Cx), forming hexameric hemi-
channels (connexons). A gap junction is formed by two
hemichannels from adjacent cells [2]. Gap junctions are
non-specific channels exhibiting low electrical resistance
and allowing passage of small molecules with a molecular
mass of less than 1.5 kDa [1]. Alterations in this cellular
communication system could play a role in modulating the
response to certain stimuli and in coordinating cellular0008-6363/$ - see front matter D 2003 European Society of Cardiology. Publishe
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of endothelial cells requires communication through gap
junctions [3] and gap-junctional communication is consis-
tently enhanced in migrating endothelial cells [4]. Endothe-
lial cells express mainly Cx43, 40 and 37 [5], which allows a
variety of homo- and heterotypic channels to be formed [6].
Regulation of gap-junctional communication in response
to physiological stimuli occurs at different levels. Changes in
gap-junctional coupling may be mediated by alterations of
single channel electrical conductances or the open probability
of gap-junction channels [7]. Alternatively, cell coupling may
be influenced by the balance between the incorporation of
new Cx into the plasma membrane and their degradation, a
very potent mechanism as evidenced by the unusually short
half-life of 1–3 h of Cx in the membrane [8,9]. In this context,
phosphorylation of connexins might play a role as their
intracellular C-termini contain phosphorylation sites for a
variety of protein kinases [10]. Mitogen-activated protein
kinase (MAPK), protein kinase C (PKC) and v-Src kinase are
able to phosphorylate Cx43 [11]. Similarly, the C terminus ofd by Elsevier B.V. All rights reserved.
A. Hoffmann et al. / Cardiovascular Research 60 (2003) 421–430422Cx40 contains phosphorylation sites for PKC-, cGMP- or
cAMP-dependent protein kinase [12]. Changes in the phos-
phorylation status of Cx have been shown to mediate alter-
ations in cell coupling and gap junctional single conductance
state [13,14].
Several studies also show the importance of gap-junction-
al coupling not only between endothelial cells, but alsoFig. 1. Cell coupling in HUVEC- and Cx-transfected HeLa cells. (A) Flow cytom
following the increase in double-stained cells over coincubation time. FL-1: calc
stained HUVEC increased linearly over time (n= 35). (C) The percentage of double
cells not expressing connexins showed no detectable dye transfer. In the other
statistically significant ( p< 0.05). The percentage of double-stained cells dependebetween endothelium and smooth muscle. The vasodilatory
effect of the endothelium-derived hyperpolarizing factor
(EDHF) seems to be dependent on gap junctions between
endothelial and smooth muscle cells [15,16]. Cellular com-
munication through gap junctions is also required for the
propagation of vasomotor signals along the vessels [17].
Under in vivo conditions, an attenuation of a conductedetry diagrams showing two differently labelled cell populations and in the
ein fluorescence, FL-2: PKH fluorescence. (B) The percentage of double-
-stained cells showed an increase over time in Cx-expressing cells. HeLa-wt
experimental groups (with the exception Cx43–Cx40), dye transfer was
d on the kind of Cx present in the cells (n= 35).
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owdilation caused by acetylcholine was found in Cx40-deficient
mice [18], further emphasizing the role of Cx in regulating
local vascular tone. Though the role of nitric oxide (NO) in
the regulation of gap junctional coupling has been examined
in some cell types [19,20], so far, little is known about the
influence of this vasoactive factor on coupling between
vascular cells. This mediator is of special interest because it
is involved not only in vasodilatation, but also in cell
migration, proliferation, inflammation and angiogenesis,
where de novo formation of gap junctions might be especially
important. Therefore, we investigated whether and by which
cellular mechanisms NO affects gap-junctional communica-
tion of endothelial cells (human umbilical vein endothelialFig. 2. Reduction of dye transfer by different inhibitors of gap-junctional coupling
junction inhibitor octanol inhibited dye transfer concentration dependently wi
fluorescence. (B) Statistical analysis displaying that the gap-junctional inhibitors 1
(n= 5–7). *p< 0.05 vs. control. (C) Confocal laser scanning micrograph of calcein
of an unlabelled HUVEC monolayer. Left: phase contrast, middle: calcein fluores
generation; arrow 3: recipient cell, 2nd generation. The white line indicates the pcells, HUVEC) in a coincubation model, which favours de
novo formation of gap junctions. We further investigated
whether potential effects of NO on endothelial cell coupling
could be attributed to effects on one single type of connexin
or were due to a general effect on all of them.2. Methods
2.1. Cell culture
Endothelial cells were isolated from freshly obtained
human umbilical cord veins (HUVEC) according to Jaffe etin HUVEC. (A) Flow cytometry diagrams of HUVEC depict that the gap
th complete inhibition at 5mM. FL-1: calcein fluorescence, FL-2: PKH
8a-glycyrrhetinic acid and p-gap27 inhibited dye transfer by about 50–60%
spreading between HUVECs. Calcein-labelled HUVECs were placed on top
cence, right: z-sectioning. Arrow 1: donor cell; arrow 2: recipient cell, 1st
osition where the z-scan was performed.
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Fig. 3. Influence of NO on cell coupling. (A) Preincubation of HUVEC
with L-NA and SOD had no effect on gap-junctional coupling, but addition
of the NO donor SNAP enhanced cell coupling (n= 25–31). (B) SNAP
increased gap-junctional coupling in a concentration-dependent manner
(n= 7–11). *p< 0.05 vs. untreated control.
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 al. [21]. Briefly, veins were filled with phosphate-buffered
saline containing 2.4 U/ml dispase (Roche, Mannheim,
Germany). After 30 min, incubation-detached cells were
harvested and seeded into cell culture flasks using endothelial
cell growth medium (Promocell, Heidelberg, Germany).
After reaching confluence, HUVECs were sub-cultivated in
a humidified atmosphere at 37 jC and 5% CO2. In all ex-
periments, only cells of second and third passage were used.
For studying effects of individual types of connexins,
human cervical carcinoma cells (HeLa, ECACC No.
96112022) transfected with expression vectors containing
either one of the coding sequences for murine connexin 43,
40 or 37 were used [22] with wild-type HeLa cells as
controls. These cells were a generous gift from Prof. Wil-
lecke, Bonn. HeLa cells were cultivated in DMEM, 10%
FCS, 2.5 mM glutamine and antibiotics (penicillin and
streptomycin). For connexin transfected HeLa cells, the
medium was supplemented with 1 Ag/ml puromycin (Sigma,
Deisenhofen, Germany).
Confluent HeLa or HUVEC monolayers were studied
under control conditions or after incubation with one or a
combination of the following compounds:
NN-nitro-L-arginine (L-NA, 30 AM, 45 min)
superoxide dismutase (SOD, 200 U/ml, 30 min)
1-H-[1,2,4]-oxadiazole-[4,3]-quinoxalin-1-one (ODQ, 10
AM, 45 min)
8-Br-cGMP (100 AM, 30 min)
Brefeldin A (BFA, 2 mM, 30 min)
18a-glycyrrhetinic acid (50/500 AM, 20 min)
p-gap27 (SRPTEKTVFTV-OH, 500 AM, 20 min)
forskolin (FSK, 100 AM, 20 min)
N-[2-p-Bromocinnamylamino)ethyl]-5-isoquinolinesul-
fonamide2HCl (H89, 1 AM, 30 min)
S-nitroso-N-acetyl-DL-penicillamine (SNAP, 1 AM, 15
min).
Sham-treated cells from the same culture batch served as
corresponding controls for paired studies.
2.2. Quantification of cell communication
To determine cell coupling, a flow cytometry based
method according to Tomasetto et al. [23] was used. In
brief, populations of confluent HUVEC or HeLa mono-
layers were labeled with calcein-acetoxymethyl ester (0.1
AM, 10 min, Molecular Probes, Eugene, OR, USA) in 24-
well dishes. This form of dye is membrane permeable and is
converted to an impermeable one after cleavage by intra-
cellular esterases. Prior to incubations with different agents
as indicated above, remnants of calcein dye were removed
by triplicate washings in PBS.
A second cell population (dye acceptor cells) that had been
labeled with the membrane-bound dye PKH26 (5 AM, 5 min,
Sigma) was trypsinized and added to the calcein-labeled
donor cells. Coincubation was initiated by centrifugation(15 g for 3 min) and lasted for various periods of time to
allow for dye transfer. Subsequently, the only loosely at-
tached acceptor cells were removed by washing and analyzed
by flow cytometry (>10,000 acceptor cells) for double stain-
ing, indicating transfer of the calcein dye into the PKH-
labeled cells. The fluorescence was measured (FACScan,
Becton-Dickinson, Heidelberg, Germany) at an excitation
wavelength of 488 nm. Emission light of calcein and PKH
was determined at 530 (FL-1) and 575 nm (FL-2), respec-
tively. Dot plots (FL-1/FL-2) were analyzed using Cell quest
3.1k software. Dye coupling was determined as percentage
of double stained cells.
2.3. Western blotting
Confluent HUVEC or HeLa cells were collected in lysis
buffer (20 mM KH2PO4 pH 7.0, 1 mM EDTA, 1 mM Pefa
blockR, 10 Ag/ml aprotinin, 0.5 mg/ml leupeptin, 0.7 Ag/ml
pepstatin, 50 mM NaF, 40 mM Na-pyrophosphate and 1 mM
Na3VO3) and kept at 4 jC overnight. Triton X-100 was added
to a final concentration of 1% and the samples were incubated
further on ice for 30 min. For crude membrane preparation,
two thirds of the lysate was centrifuged for 2.5 h (10,000 g,
4 jC), whereas one third was saved as ‘‘total cell lysate’’. The
Table 1
NO exerted no effect on cell coupling mediated by Cx43 or Cx37
Cx43–43 (%) Cx43–37 (%) Cx37–37 (%)
L-NA 12.4F 9.6 18.3F 14.1 10.7F 9.6
L-NA+SOD 18.3F 10.4 10.8F 18.6 18.4F 13.9
L-NA+SOD+SNAP 18.4F 16.4 16.9F 14.2 14.9F 12.2
HeLa cells transfected with Cx43 or Cx37 showed no NO-induced increase
in dye transfer. Values are changes in cell coupling (% of control, n= 15–
20). All data are not statistically different from the respective controls.
A. Hoffmann et al. / Cardiovascular Research 60 (2003) 421–430 425
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 supernatant of the centrifuged lysates (‘‘triton soluble frac-
tion’’) was separated from the pellet (‘‘triton insoluble
fraction’’). Preparations were separated by SDS-PAGE
(10%) and transferred onto a nitrocellulose membrane
(Optitran, Schleicher and Schuell, Dassel, Germany) using
a semi-dry blotting device (1 h, 0.7 mA/cm2). After block-
ing, the membrane was probed overnight at 4 jC with
specific antibodies to either Cx43 (Transduction laborato-
ries, Lexington, KY), Cx40 or Cx37 (Biotrend, Cologne,
Germany). Specific bands were identified using horserad-
ish-conjugated 2nd antibodies (Sigma) and chemi-lumines-
cence reaction with luminol and cumaric acid as substrates
(Sigma).
2.4. Measurement of intracellular cGMP and CAMP
Cyclic nucleotide concentrations were determined with
the 125I proximity assay (SPA) system (Amersham Pharmacia
Biotech, Freiburg, Germany). In case of cGMPmeasurement,
the culture medium was replaced by 100 Al Lockes solution
pH 7.4 (154 mM NaCl, 5.6 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mMHEPES, 3.6 mMNaHCO3, 5.6 mM dextrose)
supplemented with the phosphodiesterase inhibitor Zaprinast
(30 AM). HUVECs were incubated with either SNAP or 8-Br-
cGMP. To determine intracellular cGMP, the Lockes solutionFig. 4. Increase in cell coupling by NO is mediated via Cx40. NO enhanced gap-jun
vs. control.was replaced by ice cold 50 mM NaAc (pH 4.0). For
determination of total cAMP levels (intracellular and cell
supernatant cAMP), Lockes solution was not removed.
Finally, cells and their supernatants were lysed by snap
freezing in liquid nitrogen and used for the assay as described
in the manufacturer’s manual.
2.5. Materials
Unless indicated otherwise, all chemicals were of ana-
lytical grade and were purchased from Sigma. p-gap27
(SRPTEKTVFTV-OH), a peptide homologous to the extra-
cellular gap27 sequence of Cx32 that has been identified as
an effective gap junction blocker [24], was synthesized by
BioSource (Solingen, Germany) and dissolved in PBS with
0.7 mM Ca2 + and 0.25 mM Mg2 +.
2.6. Confocal microscopy
To test whether dye transfer was specific and locally
limited, confocal images were obtained of calcein-labelled
HUVEC, coincubated with HUVEC that had been grown on
glass cover slips. Dye transfer was visualized with a Zeiss
LSM 410 confocal microscope and a 60 oil immersion
objective. Z-sections were obtained using the LSM 410
software.
2.7. Data analysis
All values are expressed as meansF S.E.M. Data were
analyzed for statistical differences by the Student’s t-test for
paired data. Differences were considered significant when
the error probability was pV 0.05 (treatment vs. time-
matched control after testing normal distribution of the
differences).ctional coupling in HeLa cells transfected with Cx40 (n= 20–25). *p< 0.05
uenchen on January 24, 2013
Fig. 5. The increase in Cx40 coupling depended on cGMP. In HUVECs and
HeLa transfectants, the increase of coupling by SNAP was abolished by
ODQ (inhibitor of guanyl cyclase). Themembrane permeable analogue 8-Br-
cGMP mimicked the effect of SNAP (n= 20–25). *p< 0.05 vs. SNAP.
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 3. Results
3.1. Cell coupling of unstimulated HUVEC and HeLa cells
Cell coupling increased linearly with coincubation time.
The percentage of double-stained HUVECs amounted to
3.1F 0.3%, 8.2F 0.8%, 33.3F 1.8% and 64.8F 2.3% after
5, 15, 90 and 180min, respectively (n = 35, Fig. 1A,B). In Cx-
deficient HeLa wild-type (HeLa-wt) cells, virtually no dou-
ble-stained cells ( < 2%) could be detected, even after 90 min
of coincubation (Fig. 1C). This seems to be the ‘‘back-
ground’’ dye transfer in our model. HeLa cells transfected
with either Cx43, 40 or 37 showed time-dependent dye
transfer. The quantitative amount was dependent on the type
of the Cx: coupling of Cx43 HeLa cells with Cx43, as well as
coupling of Cx43 with Cx37 HeLa cells, showed the highest
amount of double-stained cells, to an extent that was com-
parable to HUVECs. Dye transfer was significantly lower in
homomeric as well as homomerical–heterotypical coupling
of HeLa Cx40 and Cx37 cells (Fig. 1C). Cx40 and Cx43
showed virtually now coupling ( < 2%), as has been described
before in these HeLa cells [22]. The gap junction inhibitor
octanol completely inhibited dye transfer (Fig. 2A). 18a-
glycyrrhetinic acid, a different gap junction blocker, attenu-
ated the percentage of double-stained HUVEC in a concen-
tration-dependent manner by  35.5F 7.7% (50 AM, n = 7)
and  49.3F 5.3% (500 AM, n = 7). A gap junction inhibi-
tory peptide [24] also decreased dye transfer by  57.6F
12.3% (500 AM, n = 5) as compared to untreated HUVEC
(Fig. 2B).
The specificity and local limitation of dye transfer was
visualized by confocal microscopy. Fig. 2C depicts a z-
section through the calcein donor cell as well as through two
recipient cells.
3.2. NO enhances gap-junctional coupling
To investigate the effect of NO on gap-junctional coupling
independent of endogenous formation of NO by NO synthase
or consumption of NO by endothelial superoxide, we pre-
incubated HUVECs with L-NA, an inhibitor of NO synthase
and the enzyme SOD. L-NA alone or in combination with
SOD had no effect on dye transfer. In contrast, addition of the
NO donor SNAP (1 AM) increased the percentage of double
stained cells by + 40.9F 15.0% (n = 31, Fig. 3A). The
SNAP-induced increase in dye coupling was concentration
dependent over a wide range (10 10–10 6 M; Fig. 3B).
Interestingly, SNAP in a concentration of 10 4 M no longer
increased cell coupling (Fig. 3B).
3.3. The NO-induced rise in cell coupling is mediated by
Cx40
As HUVECs express Cx43, 40 and 37, we examined the
effect of NO on specific types of connexin in HeLa cells
transfected with either one of these Cx. HeLa cells transfectedwith Cx43 or Cx37 showed no increase in dye transfer when
incubated with SNAP. The same was true for coupling of
Cx43 with Cx37 (Table 1). In contrast, SNAP increased the
percentage of double-stained cells in only Cx40-transfected
HeLa cells by + 97.8F 26.4% (n= 24), and in HeLa Cx40
cells when coupled with Cx37 transfected HeLa cells
( + 50.2F 12.4%, n = 24, Fig. 4).
3.4. The increase in Cx40-dependent coupling is mediated
by cyclic nucleotide-dependent mechanisms involving acti-
vation of PKA
cGMP measurements in HUVEC showed a SNAP-in-
duced rise in cGMP ( + 81.3F 28.9%, n = 10), which could
Fig. 7. NO-induced redistribution of Cx40 from the triton-soluble cell lysate
to the triton-insoluble fraction. As detected by western blot, SNAP induced
a PKA-mediated redistribution of Cx40 from the triton-soluble fraction to
the triton-insoluble fraction which was inhibited by the PKA inhibitor H89
(n= 15–16). *p< 0.05 vs. untreated control.
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 be inhibited by ODQ, an inhibitor of the soluble guanylyl
cyclase ( 14.1F14.6%, n = 8). Preincubation of HUVECs
as well as of Cx40-transfected HeLa cells with ODQ pre-
vented the SNAP-induced increase in dye transfer (Fig. 5).
Conversely, 8-Br-cGMP, a stable membrane permeant cGMP
analogue, increased the percentage of double-stained cells to
a similar extent as SNAP (Fig. 5), an effect which was
pronounced most when only Cx40 was present. As we could
not detect cGMP-dependent protein kinase in HUVEC
lysates via western blot (data not shown), we investigated
whether cGMP affected the cAMP level through its known
effect on a cGMP-dependent phosphodiesterase (PDEIII).
Treatment of HUVECs with SNAP or 8-Br-cGMP indeed
increased cAMP levels by + 22.4F 3.3% (n = 8) or + 22.3F
6.9% (n = 16).
The cAMP-elevating compound forskolin (FSK) also
enhanced the percentage of double-stained cells by + 102F
12.1% (n = 66, Fig. 6). This increase was reduced after
preincubation with the protein kinase A (PKA) inhibitor
H89 by about 50% (n= 31). The 8-Br-cGMP-induced in-
crease in dye transfer was similarly reduced by H89 (n = 32,
Fig. 6). Treatment of HUVECs with a combination of FSK
and 8-Br-cGMP enhanced cell coupling synergistically
( + 181.2F 27.3%, n = 25, Fig. 6). H89 alone had no effect
on coupling.
3.5. cAMP-induced PKA-dependent increase of transloca-
tion of Cx40 into the cell membrane
To distinguish whether NO increased the permeability for
fluorescent dye of existing gap junctions or augmented
incorporation of new Cx into the plasma membrane,
HUVECs were incubated with Brefeldin A (BFA). BFA,Fig. 6. The NO-induced increase in cell coupling is mediated by activation
of PKA. Elevation of intracellular cAMP by forskolin (FSK) or 8-Br-cGMP
(cGMP) enhanced coupling in HUVECs. This was PKA dependent, as both
the FSK- and 8-Br-cGMP-induced increase in dye transfer was partially
inhibited by the PKA inhibitor H89 (n= 50–70). #p< 0.05.which inhibits protein translocation from the Golgi apparatus
to the plasma membrane, did not affect the percentage of
double-stained cells as compared to controls ( 1.2F 9.1%,
n = 22), but prevented the SNAP-induced increase in dye
transfer ( + 2.0F 8.9%, n = 22). Furthermore, as determined
by western blot, the Cx40 distribution in cell lysates was
altered by SNAP: Cx40 in the triton-soluble fraction of the
cell lysate decreased by  14.8F 5.4% (n = 16), while it
increased it in the triton-insoluble fraction by + 28.8F12.9%
(n = 16). This SNAP-induced redistribution of Cx40 was
prevented by the PKA inhibitor H89 (n = 14–16, Fig. 7).othek M
uenchen on January 24, 20134. Discussion
This study demonstrates that NO enhances coupling
between acutely coincubated endothelial cells (HUVEC).
This is a Cx40-dependent phenomenon induced by a signal
cascade involving the second messengers cGMP and cAMP,
as well as protein kinase A. The most likely way by which
this may occur is, according to our findings, by the de novo
formation of gap junctions from preexisting Cx.
To determine gap-junctional coupling, we used a well-
established flow cytometric method described by Tomasetto
et al. [23] and others [25]. With this experimental setup, dye
transfer is not determined within a confluent monolayer
where cells are already coupled. Rather, de novo formation
of gap junctions between two different cell populations is
studied. Control experiments (no dye transfer between
HeLa-wt, 50–100% inhibition of cell coupling with three
different gap-junction inhibitors, direct visualization of dye
distribution by confocal microscopy) confirmed that dye
transfer was indeed dependent on gap junctions.
To determine the effect of NO on gap-junctional coupling,
we used SNAP, a NO donor which significantly enhanced
A. Hoffmann et al. / Cardiovascular Research 60 (2003) 421–430428
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 gap-junctional coupling even in concentrations as low as
10 10 M. The maximum effect was observed at 1 AMSNAP,
corresponding to about 2 nM NO [26]. Since agonists that
cause liberation of endogenous NO from HUVECs (e.g.
bradykinin) do so by increasing intracellular calcium levels
and, thereby, induce a broad variety of signal cascades, we did
not examine such drugs, but solely added NO exogenously.
Though this is a limitation of our study, the broad range of
concentrations of SNAP employed should fall within the
nanomolar range of physiologically occurring NO levels.
A possible inactivation of endogenous or exogenous NO
by superoxide anions which are produced under basal con-
ditions in endothelial cells [27] was excluded by supplement-
ing superoxide dismutase (SOD). Surprisingly, SNAP con-
centrations of 10 4 M did not increase cell coupling,
suggesting an inhibitory effect of the highly reactive NO on
a variety of signal molecules, as NO in higher concentrations
is known to oxidize—SH or nitrosylate—OH groups of
proteins [28]. Effects of NO can be sometimes be related to
an indirect action of this small reactive molecule as a radical
scavenger [29]. However, since SOD had no effect per se in
our model, it is unlikely that the decrease of superoxide levels
by NO played a role in the observed changes of cell coupling.
As HUVECs express three different types of connexins,
Cx43, Cx40, and Cx37 [5], we analyzed whether the effects
of NO on endothelial cell coupling could be specifically
attributed to one single Cx. For these experiments, HUVECs
were unsuitable as their various connexins could not be
analyzed separately. Therefore, HeLa cells were used as
additional experimental tools, as they do not express Cx in
their wild-type form. Separate transfection with either Cx43,
Cx40 or Cx37 [22] allowed us to study the effect of NO on
only one type of connexin at a time in this model. NO had no
effect on cell coupling in Cx43- or Cx37-transfected HeLa
cells. In contrast, NO increased dye transfer when Cx40 was
present, as not only coupling of HeLa cells transfected with
Cx40 was augmented, but also gap-junctional coupling of
Cx40 in combination with Cx37.
Enhanced coupling byNO inHUVECs as well as in Cx40-
transfected HeLa cells was mediated by cGMP: cGMP levels
rose after treatment with SNAP, preincubation with an
inhibitor of the soluble guanylyl cyclase, ODQ, abolished
the increase in NO-induced cell coupling and a stable cGMP
analogue, 8-Br-cGMP, mimicked the NO effect. Usually,
cGMP-dependent effects of NO are mediated by a cGMP-
dependent kinase (PKG), e.g. in smooth muscle cells [30].
However, in agreement with previous investigations [30], we
could not detect PKG in HUVEC cell lysates (data not
shown), making a role for PKG in this context very unlikely.
Since cGMP is known to directly affect the activity of cAMP-
cleaving phosphodiesterases (PDE) II and III in many cell
types [31], we investigated whether NO also affected intra-
cellular cAMP levels. Since intracellular cAMP concen-
trations in HUVEC increased after NO or 8-Br-cGMP
stimulation, and since the adenylyl cyclase activator forskolin
(FSK) had an even higher effect than NO, it seemsmost likelythat an increase of cAMP is mandatory for the rise in cell
coupling due to treatment with SNAP. A cGMP-dependent
inhibition of PDE III by the NO donor sodium nitroprusside
was observed in the isolated perfused rat kidney, leading to
increased cAMP levels [32]. The combination of 8-Br-cGMP
with FSK enhanced endothelial cell coupling in a synergistic
manner. Likewise, nitroprusside enhanced cAMP levels in
platelets causing synergistic effects with an adenylyl cylcase
activator on platelet function [33]. Synergistic effects of
cAMP- and cGMP-elevating vasodilators were also found
in the microcirculation in vivo [34]. The cAMP-dependent
increase in cell coupling was presumably mediated by protein
kinase A (PKA), as the PKA inhibitor H89 blocked both the
increase in gap-junctional coupling due to forskolin as well as
that induced by 8-Br-cGMP. The exact mode of action can,
however, not be determined in our model, since in addition to
indirect effects of cGMP on PKA via inhibition of phospho-
diesterases, also direct activation of PKA by cGMP has been
described [35,36]. Thus, the increase of cAMP we have seen
after treatment with SNAP could only be an epiphenomenon.
Whether the influence on gap-junctional coupling by NO or
by mediators directly activating PKA is more prominent in
vivo cannot be decided at the moment.
Though our experimental model was designed to analyze
de novo formation of gap junctions, it cannot be fully
excluded that NO might also modulate the conductivity of
already existing gap junctions. Therefore, to determine
whether PKA activation by NO increased incorporation of
Cx into the plasma membrane, HUVECs were preincubated
with Brefeldin A (BFA), which inhibits the translocation of
proteins from the Golgi apparatus to the plasma membrane.
The fact that BFA pretreatment blocked the SNAP-induced
increase in gap-junctional coupling strongly suggests that NO
indeed augmented cell coupling by an enhanced incorpora-
tion of new Cx into the plasma membrane. After prolonged
BFA treatment (>90 min), gap-junctional coupling was
reduced by  28.5F 2.9% (n = 10, p < 0.001 vs. control;
data not shown), reflecting the short half-life of about 1.5–
3 h [9].
To further investigate the incorporation of Cx into the
plasma membrane, we determined the distribution of Cx40 in
cell lysates. Musil et al. have shown that functional Cx43
incorporated in the membrane is Triton X-100 insoluble,
possibly due to strengthened anchorage to the membrane as a
result of phosphorylation during the translocation process. In
contrast, Cx43 still processed in the ER or Golgi apparatus is
triton soluble [37]. NO decreased the amount of Cx40 in the
triton-soluble fraction of the cell lysates and correspondingly
increased it in the triton-insoluble fraction, indicating a shift
of Cx40 from the cytoplasmic compartments to the plasma
membrane under the assumption that Cx40 and Cx43 show
similar biophysical properties. This redistribution was pre-
vented by preincubation with the PKA inhibitor H89, sug-
gesting that the incorporation of Cx into the plasma
membrane required PKA activation. PKA mediated de novo
formation of gap junctions from preexisting connexins could
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 be induced in several ways: the constant flux of Cx to the
plasma membrane is mediated by a vesicular transport
pathway [38,39], and PKA plays a role in the incorporation
of vesicles into the plasma membrane and facilitates their
docking [40–42]. Alternatively, PKA could directly phos-
phorylate Cx40, since all three endothelial connexins, Cx43,
Cx40 and Cx37, possess putative phosphorylation sites for
PKA [12,43–45]. It has been shown that Cx43 phosphory-
lation was increased by forskolin in rat granulosa cells [46].
However, treatment with 8-Br-cAMP did not alter Cx43
phosphorylation in MDCK cells [47]. Correspondingly, no
effect on permeability and conductance of Cx43 was found
after 8-Br-cAMP incubation [48]. Concerning Cx37 or Cx40,
no concisive data with respect to phosphorylation by PKA
exist. Phosphorylation might be involved in the constitutive
transport of Cx40 to the plasma membrane and its functional
incorporation. PKA might also have effects on the micro-
tubuli, which are needed to translocate connexins from
intracellular stores as recently demonstrated [49,50]. Finally,
it can also be speculated that PKA facilitates lateral diffusion
of Cx in the plasma membrane, thus enhancing the assembly
of gap junction plaques [51]. Since this last mechanism
would, in contrast to our findings (Fig. 7), not have led to
redistribution of Cx from intracellular stores to the plasma
membrane, it seems rather unlikely.
In conclusion, NO enhances de novo formation of
endothelial gap junctions, which is specific for Cx40 and
involves PKA activation. This effect is accompanied by
cGMP-dependent enhancement of cAMP levels. The result-
ing activation of PKA leads to an increased incorporation of
Cx40 into the plasma membrane. This novel action of NO
on endothelial gap-junctional coupling may be of particular
interest in the context of angiogenesis [3,4], as NO plays an
important role as an angiogenic factor modulating migration
and sprouting of endothelial cells.uenchen on January 24, 2013Acknowledgements
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